Stay updated on Talacotuzumab vs. Daratumumab in MDS Clinical Trial

Sign up to get notified when there's something new on the Talacotuzumab vs. Daratumumab in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talacotuzumab vs. Daratumumab in MDS Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s footer version marker has been updated from **Revision: v3.5.0** to **Revision: v3.5.3**, indicating a different site build/release rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-04-26T15:36:56.000Z thumbnail image
  4. Check
    57 days ago
    Change Detected
    Summary
    Revision v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-21T20:17:43.000Z thumbnail image
  5. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T08:40:19.000Z thumbnail image
  6. Check
    93 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 with no substantive changes to trial details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T00:50:55.000Z thumbnail image
  7. Check
    100 days ago
    Change Detected
    Summary
    Revision from v3.4.0 to v3.4.1 occurred with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T14:28:05.000Z thumbnail image
  8. Check
    114 days ago
    Change Detected
    Summary
    UI changes include the addition of Show glossary and Hide glossary options and capitalization tweaks to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new Revision: v3.4.0 label. There are no changes to core study content, eligibility criteria, or data presented on the page.
    Difference
    0.3%
    Check dated 2026-01-23T10:20:27.000Z thumbnail image

Stay in the know with updates to Talacotuzumab vs. Daratumumab in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talacotuzumab vs. Daratumumab in MDS Clinical Trial page.